BDNF parabrachio-amygdaloid pathway in morphine-induced analgesia

International Journal of Neuropsychopharmacology

Volumn 16, Issue 7, 2013, Pages 1649-1660

  Sarhan, Maysa ^a   Pawlowski, Sophie Anne ^a,b   Barthas, Florent ^a,b   Yalcin, Ipek ^b   Kaufling, Jennifer ^a,b   Dardente, Hugues ^c   Zachariou, Venetia ^d   Dileone, Ralph Joseph ^e   Barrot, Michel ^b   Veinante, Pierre ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b CNRS   (France)

^c CEMAGREF   (France)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain derived neurotrophic factor; extended amygdala; morphine; pain; parabrachio amygdaloid pathway

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; MORPHINE;

ADENO ASSOCIATED VIRUS; ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; GENE DELETION; HISTOPATHOLOGY; IMMUNOREACTIVITY; MALE; MOTOR PERFORMANCE; MOUSE; NERVE TRACT; NONHUMAN; ONCOGENE C FOS; OPEN FIELD TEST; PAIN THRESHOLD; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; ROTAROD TEST;

AMYGDALA; ANALGESICS, OPIOID; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DARK ADAPTATION; DEPENDOVIRUS; EXPLORATORY BEHAVIOR; HYPERALGESIA; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MORPHINE; NEURAL PATHWAYS; PAIN MEASUREMENT; PAIN THRESHOLD; PONS; PROTO-ONCOGENE PROTEINS C-FOS; ROTAROD PERFORMANCE TEST;

EID: 84880540204     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571200168X     Document Type: Article

References (62)

1. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM (2008) Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 63:642-649.
2. Agassandian K, Gedney M, Cassell MD (2006) Neurotrophic factors in the central nucleus of amygdala may be organized to provide substrates for associative learning. Brain Res 1076:78-86.
3. Alheid GF, De Olmos JS, Beltramino CA (1995) Amygdala and extended amygdala. In : The rat nervous system (Paxinos G, ed), pp495-578. New York: Academic Press Inc.
4. Barrot M (2012) Tests and models of nociception and pain in rodents. Neuroscience 211:39-50.
5. Bernard JF, Bester H, Besson JM (1996) Involvement of the spino-parabrachio-amygdaloid and -hypothalamic pathways in the autonomic and affective emotional aspects of pain. Prog Brain Res 107:243-255.
6. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-868.
7. Cassell MD, Freedman LJ, Shi C (1999) The intrinsic organization of the central extended amygdala. Ann NY Acad Sci 877:217-241.
8. Ceccatelli S, Ernfors P, Villar MJ, Persson H, Hokfelt T (1991) Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc Natl Acad Sci USA 88:10352-10356.
9. Chieng B, Christie MJ (2009) Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey. Neuropharmacology 57:430-437.
10. Chieng BC, Christie MJ, Osborne PB (2006) Characterization of neurons in the rat central nucleus of the amygdala: cellular physiology, morphology, and opioid sensitivity. J Comp Neurol 497:910-927.
11. Ciocchi S, Herry C, Grenier F, Wolff SB, Letzkus JJ, Vlachos I, Ehrlich I, Sprengel R, Deisseroth K, Stadler MB, Muller C, Luthi A (2010) Encoding of conditioned fear in central amygdala inhibitory circuits. Nature 468:277-282.
12. Cirulli F, Berry A, Alleva E (2000) Intracerebroventricular administration of brain-derived neurotrophic factor in adult rats affects analgesia and spontaneous behaviour but not memory retention in a Morris Water Maze task. Neurosci Lett 287:207-210.
13. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-2313.
14. Cui XY, Lundeberg T, Yu LC (2004) Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in rats. Brain Res 995:23-28.
15. Davis M, Walker DL, Miles L, Grillon C (2010) Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35:105-135.
16. Delaney AJ, Crane JW, Sah P (2007) Noradrenaline modulates transmission at a central synapse by a presynaptic mechanism. Neuron 56:880-892.
17. Deyama S, Nakagawa T, Kaneko S, Uehara T, Minami M (2007) Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behav Brain Res 176:367-371.
18. Finnegan TF, Chen SR, Pan HL (2005) Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala. J Pharmacol Exp Ther 312:441-448.
19. Franklin KB, Paxinos G (2008) The mouse brain in stereotaxic coordinates, 3rd edn. New York: Academic Press.
20. Ghitza UE, Zhai H, Wu P, Airavaara M, Shaham Y, Lu L (2010) Role of BDNF and GDNF in drug reward and relapse : A review. Neurosci Biobehav Rev 35:157-171.
21. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW (2007) Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 10:1029-1037.
22. Guo W, Robbins MT, Wei F, Zou S, Dubner R, Ren K (2006) Supraspinal brain-derived neurotrophic factor signaling : A novel mechanism for descending pain facilitation. J Neurosci 26:126-137.
23. Hamlin AS, McNally GP, Osborne PB (2007) Induction of c-Fos and zif268 in the nociceptive amygdala parallel abstinence hyperalgesia in rats briefly exposed to morphine. Neuropharmacology 53:330-343.
24. Han JS, Adwanikar H, Li Z, Ji G, Neugebauer V (2010) Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats. Molecular Pain 6 :10.
25. Han Y, Yu LC (2009) Involvement of oxytocin and its receptor in nociceptive modulation in the central nucleus of amygdala of rats. Neurosci Lett 454:101-104.
26. Haubensak W, Kunwar PS, Cai H, Ciocchi S, Wall NR, Ponnusamy R, Biag J, Dong HW, Deisseroth K, Callaway EM, Fanselow MS, Luthi A, Anderson DJ (2010) Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 468:270-276.
27. Helmstetter FJ (1993) Stress-induced hypoalgesia and defensive freezing are attenuated by application of diazepam to the amygdala. Pharmacol Biochem Behav 44:433-438.
28. Helmstetter FJ, Bellgowan PS, Tershner SA (1993) Inhibition of the tail flick reflex following microinjection of morphine into the amygdala. Neuroreport 4:471-474.
29. Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ (2003) Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 9 :1539-1544.
30. Horch HW (2004) Local effects of BDNF on dendritic growth. Rev Neurosci 15:117-129.
31. Huang GF, Besson JM, Bernard JF (1993a) Morphine depresses the transmission of noxious messages in the spino(trigemino)-ponto-amygdaloid pathway. Eur J Pharmacol 230:279-284.
32. Huang GF, Besson JM, Bernard JF (1993b) Intravenous morphine depresses the transmission of noxious messages to the nucleus centralis of the amygdala. Eur J Pharmacol 236:449-456.
33. Jaferi A, Pickel VM (2009) Mu-opioid and corticotropinreleasing- factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis. Neuroscience 159:526-539.
34. Kalivas PW, Gau BA, Nemeroff CB, Prange Jr. AJ (1982) Antinociception after microinjection of neurotensin into the central amygdaloid nucleus of the rat. Brain Res 243:279-286.
35. Kaufling J, Veinante P, Pawlowski SA, Freund-Mercier MJ, Barrot M (2009) Afferents to the GABAergic tail of the ventral tegmental area in the rat. J Comp Neurol 513:597-621.
36. Knobloch HS, Charlet A, Hoffmann LC, Eliava M, Khrulev S, Cetin AH, Osten P, Schwarz MK, Seeburg PH, Stoop R, Grinevich V (2012) Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 73:553-566.
37. Koo JW, Mazei-Robison MS, Chaudhury D, Juarez B, LaPlant Q, Ferguson D, Feng J, Sun H, Scobie KN, Damez-Werno D, Crumiller M, Ohnishi YN, Ohnishi YH, Mouzon E, Dietz DM, Lobo MK, Neve RL, Russo SJ, Han MH, Nestler EJ (2012) BDNF is a negative modulator of morphine action. Science 338:124-128.
38. Krause S, Schindowski K, Zechel S, von Bohlen und Halbach O (2008) Expression of trkB and trkC receptors and their ligands brain-derived neurotrophic factor and neurotrophin-3 in the murine amygdala. J Neurosci Res 86:411-421.
39. Lucas G, Hendolin P, Harkany T, Agerman K, Paratcha G, Holmgren C, Zilberter Y, Sairanen M, Minichiello L, Castren E, Ernfors P (2003) Neurotrophin-4 mediated TrkB activation reinforces morphine-induced analgesia. Nat Neurosci 6 :221-222.
40. Manning BH, Mayer DJ (1995) The central nucleus of the amygdala contributes to the production of morphine antinociception in the rat tail-flick test. J Neurosci 15:8199-8213.
41. Manning BH, Merin NM, Meng ID, Amaral DG (2001) Reduction in opioid- and cannabinoid-induced antinociception in rhesus monkeys after bilateral lesions of the amygdaloid complex. J Neurosci 21:8238-8246.
42. Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C, Bardoni R (2008) BDNF as a pain modulator. Prog Neurobiol 85:297-317.
43. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ (2007) Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61:187-197.
44. Mou L, Heldt SA, Ressler KJ (2011) Rapid brain-derived neurotrophic factor-dependent sequestration of amygdala and hippocampal GABA(A) receptors via different tyrosine receptor kinase B-mediated phosphorylation pathways. Neuroscience 176:72-85.
45. Neugebauer V, Galhardo V, Maione S, Mackey SC (2009) Forebrain pain mechanisms. Brain Res Rev 60:226-242.
46. Oliveira MA, Prado WA (2001) Role of PAG in the antinociception evoked from the medial or central amygdala in rats. Brain Res Bull 54:55-63.
47. Palomares-Castillo E, Hernandez-Perez OR, Perez-Carrera D, Crespo-Ramirez M, Fuxe K, Perez de la Mora M (2012) The intercalated paracapsular islands as a module for integration of signals regulating anxiety in the amygdala. Brain Res 1476:211-234.
48. Pavlovic ZW, Bodnar RJ (1998) Opioid supraspinal analgesic synergy between the amygdala and periaqueductal gray in rats. Brain Res 779:158-169.
49. Pezet S, Malcangio M, McMahon SB (2002) BDNF: A neuromodulator in nociceptive pathways? Brain Res Rev 40:240-249.
50. Poulin JF, Arbour D, Laforest S, Drolet G (2009) Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis. Prog Neuropsychopharmacol Biol Psychiatry 33:1356-1365.
51. Rattiner LM, Davis M, French CT, Ressler KJ (2004) Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci 24:4796-4806.
52. Ren K, Dubner R (2007) Pain facilitation and activitydependent plasticity in pain modulatory circuitry : role of BDNF-TrkB signaling and NMDA receptors. Mol Neurobiol 35:224-235.
53. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM, Jaenisch R (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15:1748-1757.
54. Salio C, Averill S, Priestley JV, Merighi A (2007) Costorage of BDNF and neuropeptides within individual dense-core vesicles in central and peripheral neurons. Dev Neurobiol 67:326-338.
55. Sarhan M, Freund-Mercier MJ, Veinante P (2005) Branching patterns of parabrachial neurons projecting to the central extended amgydala: single axonal reconstructions. J Comp Neurol 491:418-442.
56. Tokita K, Inoue T, Boughter Jr. JD (2010) Subnuclear organization of parabrachial efferents to the thalamus, amygdala and lateral hypothalamus in C57BL/6J mice: A quantitative retrograde double labeling study. Neuroscience 171:351-365.
57. Watkins LR, Wiertelak EP, Maier SF (1993) The amygdala is necessary for the expression of conditioned but not unconditioned analgesia. Behav Neurosci 107:402-405.
58. Xu W, Lundeberg T, Wang YT, Li Y, Yu LC (2003) Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway. Neuroscience 118:1015-1022.
59. Yalcin I, Charlet A, Cordero-Erausquin M, Tessier LH, Picciotto MR, Schlichter R, Poisbeau P, Freund-Mercier MJ, BarrotM(2011) Nociceptive thresholds are controlled through spinal beta(2)-subunit-containing nicotinic acetylcholine receptors. Pain 152:2131-2137.
60. Yamano M, Hillyard CJ, Girgis S, Emson PC, MacIntyre I, Tohyama M (1988) Projection of neurotensin-like immunoreactive neurons from the lateral parabrachial area to the central amygdaloid nucleus of the rat with reference to the coexistence with calcitonin gene-related peptide. Exp Brain Res 71:603-610.
61. Yan Q, Rosenfeld RD, Matheson CR, Hawkins N, Lopez OT, Bennett L, Welcher AA (1997) Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 78:431-448.
62. Zhu W, Pan ZZ (2005) Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 133:97-103.